Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.70 USD
Change Today -0.24 / -4.86%
Volume 310.8K
PACB On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 4:00 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - PACIFIC BIOSCIENCES OF CALIF (PACB)

2013 revenues at Pacific Biosciences of California, Inc. totaled $28.2M USD, while annual losses equaled $1.26 per share.

Quarterly Earnings & Estimates - PACIFIC BIOSCIENCES OF CALIF (PACB)

Actuals vs. Estimates for PACIFIC BIOSCIENCES OF CALIF PACB

Pacific Biosciences of California, Inc.'s Quarterly Earnings

Pacific Biosciences of California, Inc. reported 2nd quarter 2014 losses of $0.27 per share on 07/26/2014.

Annual Earnings & Estimates - PACIFIC BIOSCIENCES OF CALIF (PACB)

Actuals vs. Estimates for PACIFIC BIOSCIENCES OF CALIF PACB

Pacific Biosciences of California, Inc.'s Annual Earnings

Pacific Biosciences of California, Inc. reported annual 2013 losses of $1.26 per share on 02/6/2014.

Quarterly Revenues - PACIFIC BIOSCIENCES OF CALIF (PACB)

Actuals vs. Estimates for PACIFIC BIOSCIENCES OF CALIF PACB

Pacific Biosciences of California, Inc.'s Quarterly Revenues

Pacific Biosciences of California, Inc. had 2nd quarter 2014 revenues of $11.4M USD. This bettered the $11.4M USD consensus of the 4 analysts covering the company. This was 88.9% above the prior year's 2nd quarter results.

Annual Revenues - PACIFIC BIOSCIENCES OF CALIF (PACB)

Actuals vs. Estimates for PACIFIC BIOSCIENCES OF CALIF PACB

Pacific Biosciences of California, Inc.'s Annual Revenues

Pacific Biosciences of California, Inc. had revenues for the full year 2013 of $28.2M USD. This was 8.5% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PACB:US $4.70 USD -0.24

PACB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzo Biochem Inc $2.94 USD +0.02
Fluidigm Corp $11.03 USD -0.34
NanoString Technologies Inc $15.00 USD +0.14
Sequenom Inc $2.00 USD -0.04
WaferGen Bio-systems Inc $1.05 USD -0.02
View Industry Companies
 

Industry Analysis

PACB

Industry Average

Valuation PACB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.5x
Price/Book 10.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIFIC BIOSCIENCES OF CALIF, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.